Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin
Tiffany Tang, Javier A. Jaimes, Miya K. Bidon, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 2, pp. 264-272
Open Access | Times Cited: 148

Showing 26-50 of 148 citing articles:

Inhibitors of L-Type Calcium Channels Show Therapeutic Potential for Treating SARS-CoV-2 Infections by Preventing Virus Entry and Spread
Marco R. Straus, Miya K. Bidon, Tiffany Tang, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 10, pp. 2807-2815
Open Access | Times Cited: 40
Why All the Fury over Furin?
Essam Eldin A. Osman, Alnawaz Rehemtulla, Nouri Neamati
Journal of Medicinal Chemistry (2021) Vol. 65, Iss. 4, pp. 2747-2784
Closed Access | Times Cited: 37
Should we discount the laboratory origin of COVID-19?
Rossana Segreto, Yuri Deigin, Kevin McCairn, et al.
Environmental Chemistry Letters (2021) Vol. 19, Iss. 4, pp. 2743-2757
Open Access | Times Cited: 36
Discovery and Evaluation of Entry Inhibitors for SARS-CoV-2 and Its Emerging Variants
Arpan Acharya, Kabita Pandey, Michellie Thurman, et al.
Journal of Virology (2021) Vol. 95, Iss. 24
Open Access | Times Cited: 34
Drugs that offer the potential to reduce hospitalization and mortality from SARS-CoV-2 infection: The possible role of the sigma-1 receptor and autophagy
James Michael Brimson, Mani Iyer Prasanth, Dicson Sheeja Malar, et al.
Expert Opinion on Therapeutic Targets (2021) Vol. 25, Iss. 6, pp. 435-449
Open Access | Times Cited: 33
Identification and differential usage of a host metalloproteinase entry pathway by SARS-CoV-2 Delta and Omicron
Mehdi Benlarbi, Geneviève Laroche, Corby Fink, et al.
iScience (2022) Vol. 25, Iss. 11, pp. 105316-105316
Open Access | Times Cited: 27
S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
Reza Nejat, Maziar Fayaz Torshizi, David J. Najafi
Vaccines (2023) Vol. 11, Iss. 2, pp. 204-204
Open Access | Times Cited: 16
The Potential Roles of Host Cell miRNAs in Fine-Tuning Bovine Coronavirus (BCoV) Molecular Pathogenesis, Tissue Tropism, and Immune Regulation
Abid Ullah Shah, Maged Gomaa Hemida
Microorganisms (2024) Vol. 12, Iss. 5, pp. 897-897
Open Access | Times Cited: 5
Alpha-1-antitrypsin and its variant-dependent role in COVID-19 pathogenesis
Christian S. Stevens, Kasopefoluwa Y. Oguntuyo, Shreyas Kowdle, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 34
Impact of inhaled pollutants on response to viral infection in controlled exposures
Meghan E. Rebuli, Stephanie A. Brocke, Ilona Jaspers
Journal of Allergy and Clinical Immunology (2021) Vol. 148, Iss. 6, pp. 1420-1429
Open Access | Times Cited: 32
SARS-CoV-2 Delta Variant Displays Moderate Resistance to Neutralizing Antibodies and Spike Protein Properties of Higher Soluble ACE2 Sensitivity, Enhanced Cleavage and Fusogenic Activity
Sabari Nath Neerukonda, Russell Vassell, Sabrina Lusvarghi, et al.
Viruses (2021) Vol. 13, Iss. 12, pp. 2485-2485
Open Access | Times Cited: 32
A second functional furin site in the SARS-CoV-2 spike protein
Yue Zhang, Li Zhang, Jiajing Wu, et al.
Emerging Microbes & Infections (2021) Vol. 11, Iss. 1, pp. 182-194
Open Access | Times Cited: 31
How Do Enveloped Viruses Exploit the Secretory Proprotein Convertases to Regulate Infectivity and Spread?
Nabil G. Seidah, Antonella Pasquato, Ursula Andréo
Viruses (2021) Vol. 13, Iss. 7, pp. 1229-1229
Open Access | Times Cited: 30
Resources and computational strategies to advance small molecule SARS-CoV-2 discovery: Lessons from the pandemic and preparing for future health crises
Natesh Singh, Bruno O. Villoutreix
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 2537-2548
Open Access | Times Cited: 28
Endomembrane remodeling in SARS-CoV-2 infection
Di Chen, Yan Zhao, Hong Zhang
Cell Insight (2022) Vol. 1, Iss. 3, pp. 100031-100031
Open Access | Times Cited: 20
The Path to Therapeutic Furin Inhibitors: From Yeast Pheromones to SARS-CoV-2
Gary Thomas, Frédéric Couture, Anna Kwiatkowska
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3435-3435
Open Access | Times Cited: 19
COVID-19 Biogenesis and Intracellular Transport
Alexander A. Mirоnоv, M.A. Savin, Galina V. Beznoussenko
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4523-4523
Open Access | Times Cited: 12
Proteases and variants: context matters for SARS-CoV-2 entry assays
Christian S. Stevens, Kasopefoluwa Y. Oguntuyo, Benhur Lee
Current Opinion in Virology (2021) Vol. 50, pp. 49-58
Open Access | Times Cited: 26
Neuro-COVID-19: an insidious virus in action
Jolanta Bratosiewicz‐Wąsik
Neurologia i Neurochirurgia Polska (2021) Vol. 56, Iss. 1, pp. 48-60
Open Access | Times Cited: 26
(+)-Usnic acid and its salts, inhibitors of SARS‐CoV‐2, identified by using in silico methods and in vitro assay
Eunseok Oh, Weihong Wang, Kyu-Hyung Park, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 18
Protein Posttranslational Signatures Identified in COVID-19 Patient Plasma
Pavan Vedula, Hsin‐Yao Tang, David W. Speicher, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 17
Going viral in the islet: mediators of SARS-CoV-2 entry beyond ACE2
Rohita Rangu, Pandora L. Wander, Breanne M. Barrow, et al.
Journal of Molecular Endocrinology (2022) Vol. 69, Iss. 2, pp. R63-R79
Open Access | Times Cited: 17
Some natural compounds and their analogues having potent anti- SARS-CoV-2 and anti-proteases activities as lead molecules in drug discovery for COVID-19
Biswanath Dinda, Manikarna Dinda, Subhajit Dinda, et al.
European Journal of Medicinal Chemistry Reports (2022) Vol. 6, pp. 100079-100079
Open Access | Times Cited: 17
Genome-wide bioinformatics analysis of human protease capacity for proteolytic cleavage of the SARS-CoV-2 spike glycoprotein
Э. В. Матвеев, Gennady V. Ponomarev, Marat D. Kazanov
Microbiology Spectrum (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 3
Epistasis between N-terminal and receptor-binding domains drives cell entry in a bat coronavirus spike
Alexandra L. Tse, Cory M. Acreman, Inna Ricardo-Lax, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3

Scroll to top